These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14587180)

  • 1. [Smallpox vaccination. What happened to prevaccination stuff?].
    Schmitz H
    MMW Fortschr Med; 2003 Jul; 145(27-28):13. PubMed ID: 14587180
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)].
    Stickl H; Hochstein-Mintzel V; Mayr A; Huber HC; Schäfer H; Holzner A
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2386-92. PubMed ID: 4426258
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary vaccination against smallpox after preliminary vaccination with the attenuated vaccinia virus strain MVA and the use of a new "vaccination stamp"].
    Stickl H; Hochstein-Mintzel V; Huber HC
    Munch Med Wochenschr; 1973 Aug; 115(35):1471-3. PubMed ID: 4740817
    [No Abstract]   [Full Text] [Related]  

  • 5. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Our experiences with the 2-stage method of vaccination against smallpox (MVA virus pre-vaccination)].
    Rudkowski Z; Remion J; Saraczyńska E
    Pediatr Pol; 1976 May; 51(5):497-503. PubMed ID: 1272640
    [No Abstract]   [Full Text] [Related]  

  • 7. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a vaccinia virus strain used to produce smallpox vaccine in Argentina between 1937 and 1970.
    Lewis A; Bok K; Perez O; DeFillippo J; Paolazzi C; Gomez JA
    Arch Virol; 2005 Jul; 150(7):1485-91. PubMed ID: 15750861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens.
    Kastenmuller W; Gasteiger G; Stross L; Busch DH; Drexler I
    J Immunol; 2009 Mar; 182(5):2573-7. PubMed ID: 19234150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
    Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of vaccinia at the site of smallpox vaccination.
    Cummings JF; Polhemus ME; Hawkes C; Klote M; Ludwig GV; Wortmann G
    Clin Infect Dis; 2008 Jan; 46(1):101-2. PubMed ID: 18171221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current infection-control issues for smallpox disease and vaccinia vaccine.
    Bennett ME; Ledell K
    J Lab Clin Med; 2003 Oct; 142(4):239-45. PubMed ID: 14625529
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioterrorism. In search of a kinder, gentler vaccine.
    Enserink M
    Science; 2002 May; 296(5573):1594. PubMed ID: 12040158
    [No Abstract]   [Full Text] [Related]  

  • 14. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge.
    Edghill-Smith Y; Bray M; Whitehouse CA; Miller D; Mucker E; Manischewitz J; King LR; Robert-Guroff M; Hryniewicz A; Venzon D; Meseda C; Weir J; Nalca A; Livingston V; Wells J; Lewis MG; Huggins J; Zwiers SH; Golding H; Franchini G
    J Infect Dis; 2005 Feb; 191(3):372-81. PubMed ID: 15633096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Efficacy of Intramuscular and Scarification Routes of Administration of Live Smallpox Vaccine in a Murine Challenge Model.
    Phelps A; Gates AJ; Eastaugh L; Hillier M; Ulaeto DO
    Vaccine; 2017 Jul; 35(31):3889-3896. PubMed ID: 28606813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
    Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
    Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid spreading and immune evasion by vaccinia virus.
    Smith GL
    Adv Exp Med Biol; 2014; 808():65-76. PubMed ID: 24595611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing vaccinia on the external surfaces of 3 conventional bandages applied to smallpox vaccination sites in primary vaccinees.
    Waibel KH; Ager EP; Topolski RL; Walsh DS
    Clin Infect Dis; 2004 Oct; 39(7):1004-7. PubMed ID: 15472853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New generation smallpox vaccines: a review of preclinical and clinical data.
    Artenstein AW
    Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.
    Jones T
    Curr Opin Mol Ther; 2008 Aug; 10(4):407-17. PubMed ID: 18683106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.